Geode Capital Management LLC recently announced the acquisition of new stake in Neximmune Inc (NASDAQ:NEXI). The institutional investor has increased its shareholding in the Healthcare company by 75.21% to 4326.0 shares with purchase of 1857.0 shares. This fresh investment now brings its stake to 0.41% valued currently at $9604.0. In addition, Comerica Bank raised its holdings by 3257.0 to 3257.0 shares. And Renaissance Technologies LLC has lifted its position by 15.72% or 356.0 shares – to 2620.0 shares.
Currently, there are 1.04M common shares owned by the public and among those 0.66M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Neximmune Inc are Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Bridgeway Ultra Small Company Mar. Vanguard Extended Market Index Fu owns 4306.0 shares of the company’s stock, all valued at over $9559.0. Bridgeway Ultra Small Company Mar now owns shares totaling to 0.19% of the shares outstanding.
However, the script later moved the day high at 11.60, up 73.83%. The company’s stock has a 5-day price change of 64.31% and 124.64% over the past three months. NEXI shares are trading 318.92% year to date (YTD), with the 12-month market performance down to -1.85% lower. It has a 12-month low price of $1.25 and touched a high of $20.35 over the same period. NEXI has an average intraday trading volume of 1.91 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 34.26%, 110.50%, and 53.61% respectively.
Institutional ownership of Neximmune Inc (NASDAQ: NEXI) shares accounts for 14.47% of the company’s 1.04M shares outstanding. Mutual fund holders own 0.99%, while other institutional holders and individual stakeholders account for 13.48% and — respectively.
It has a market capitalization of $9.86M and a beta (3y monthly) value of 2.04. The earnings-per-share (ttm) stands at -$267.72. Price movements for the stock have been influenced by the stock’s volatility, which stands at 30.02% over the week and 32.56% over the month.
Analysts forecast that Neximmune Inc (NEXI) will achieve an EPS of $0 for the current quarter, $0 for the next quarter and $0 for 2024. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Comparatively, EPS for the current quarter was -$15 a year ago.
Looking at the support for the NEXI, a number of firms have released research notes about the stock. Raymond James stated their Outperform rating for the stock in a research note on April 01, 2021, with the firm’s price target at $30.
